Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001)
Clinical trial NCT03326986 · COMPLETED
Trial details
- NCT number
- NCT03326986
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2018-12-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.